Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey
Müçteba Enes Yayla, Burak Okyar, Emine Duygu Ersözlü, Duygu Sevinç Özgür et autres
OBJECTIVES: Anti-topoisomerase I antibody (ATA) is typically associated with diffuse cutaneous systemic sclerosis (dcSSc). However, subset of limited cutaneous SSc (lcSSc) patients also present with ATA positivity. Emerging data suggest that ATA-positive lcSSc may represent a distinct or intermediate clinical phenotype. This …
tr, ag, us, gb (code pays fourni par la source)
0 citations
Clinical and Experimental Rheumatology